Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

I-Care for MDS: Development of Guidelines-Based Indicators for Appropriate Care in Adult Patients with Myelodysplastic Syndromes

Blood (2019) 134 (Supplement_1): 4752.

https://doi.org/10.1182/blood-2019-122285

Published: 2019

Journal Articles

Is Durability of Response Reported in Refractory CTCL: A Systematic Review

Mehul R Dalal, PhD, Stephen Mitchell, PhD, Conor McCloskey, PhD, Erin Zagadailov, PharmD, MS, Ashish Gautam, PhD

Blood (2017) 130 (Supplement 1): 5598.

https://doi.org/10.1182/blood.V130.Suppl_1.5598.5598

Published: 2017

Journal Articles

Quantification of BCR-ABL with Digital PCR Results in a Significantly Lower Rate of Deep Molecular Responses When Compared to RT-qPCR in CML Patients Treated in the ENEST1st Trial

Georg-Nikolaus Franke, MD, Jacqueline Maier, PhD, Kathrin Wildenberger, Michael Cross, PhD, Oliver Frank, PhD, Frank Giles, MDMB, Andreas Hochhaus, MD, Christian T. Dietz, PhD, Martin C. Müller, Dietger Niederwieser, MD, Thoralf Lange, MD

Blood (2015) 126 (23): 135.

https://doi.org/10.1182/blood.V126.23.135.135

Published: 2015

Journal Articles

Whole Body (WB) MRI in Newly Diagnosed Multiple Myeloma (MM): Fat Fraction Changes at 8 Weeks Predict Response to Induction with Bortezomib Regimens

Arash Latifoltojar, MB BS, MSc, MPhil, Kwee L Yong, MBChB, PhD, Margaret Hall-Craggs, BA, MB BS, MD, Neil Rabin, MB,BS, PhD, Rakesh Popat, MBBS, PhD, Alan Bainbridge, Magdalena Sokolska, Nikolaos Dikaios, Shirley D'Sa, MD FRCP, FRCPath, Ali Rismani, MBBS, Shonit Punwani, Mb BS, BSc, PhD

Blood (2015) 126 (23): 1850.

https://doi.org/10.1182/blood.V126.23.1850.1850

Published: 2015

Journal Articles

Targeting Clotting Factor VIII Plasma Values in the Perioperative Setting in Hemophilia a: “Tackling a Moving Target” (“OPTI-CLOT” Studies)

Janske Lock, MD PhDstudent, Hendrika C.A.M. Hazendonk, MD PhDstudent, Ron A.A. Mathôt, Prof. Dr., Karina Meijer, MD PhD, Marjolein Peters, MD PhD, Paul Brons, Felix J.M. Van der Meer, MD PhD, Hannan Bouzariouh, MD, Mariette H.E. Driessens, PhD, Karin Fijnvandraat, MD PhD, Frank W.G. Leebeek, MD PhD, Marjon H. Cnossen, MD PhD

Blood (2014) 124 (21): 5031.

https://doi.org/10.1182/blood.V124.21.5031.5031

Published: 2014

Journal Articles

Exceeding MR5.0 Sensitivity in Routine BCR-ABL1 Analysis Using Multiplex Digital PCR

Rikke Fredslund Andersen, PhD, Niels Pallisgaard

Blood (2014) 124 (21): 4540.

https://doi.org/10.1182/blood.V124.21.4540.4540

Published: 2014

Journal Articles

Towards Successful Implementation of Pharmacokinetic-Guided Prophylactic Dosing of Clotting Factor Concentrate in Hemophilia; The Do’s and Don’ts after Discrete Choice Experiment Analysis

Janske Lock, MD PhDstudent, Esther W. de Bekker-Grob, PhD, Gamze Urhan, MD, Saskia Middeldorp, MD PhD, Marjolein Peters, MD PhD, Karina Meijer, MD PhD, Rienk Y.J. Tamminga, MD PhD, Britta Laros-van Gorkum, MD PhD, Paul Brons, Felix J.M. Van der Meer, MD PhD, Mariette H.E. Driessens, PhD, Peter W. Collins, MD, Karin Fijnvandraat, MD PhD, Frank W.G. Leebeek, MD PhD, Marjon H. Cnossen, MD PhD

Blood (2014) 124 (21): 5038.

https://doi.org/10.1182/blood.V124.21.5038.5038

Published: 2014

Journal Articles

A Comparison of Droplet Digital PCR and Quantitative RT-PCR for Low Level BCR-ABL in CML Patients with Molecular Responses

Jacqueline Maier, PhD, Georg-Nikolaus Franke, MD, Karoline Schubert, Kathrin Wildenberger, Michael Cross, PhD, Dietger Niederwieser, MD, Thoralf Lange, MD

Blood (2014) 124 (21): 1792.

https://doi.org/10.1182/blood.V124.21.1792.1792

Published: 2014

Journal Articles

Development and Evaluation of the Clinical Utility of a Next Generation Sequencing (NGS) Tool for Myeloid Disorders

Angela Hamblin, MDPhD, Adam Burns, BSc, Christopher Tham, BA, Ruth Clifford, MD, Pauline Robbe, MSc, Adele Timbs, MSc, Joanne Mason, PhD, Helene Dreau, MSc, Andreas Weller, PhD, Puthen Jithesh, PhD, Olivia Fox, BSc, Melody Tabiner, MA, Adam Mead, MDPhD, Andrew Peniket, MD, Paresh Vyas, MDPhD, Shirley Henderson, PhD, Anna Schuh, MDPhD

Blood (2014) 124 (21): 2373.

https://doi.org/10.1182/blood.V124.21.2373.2373

Published: 2014

Journal Articles

Reducing Central Venous Catheter Infection Rates Amongst Hematology Patients: Real-Life Implementation Of a ‘Matching Michigan’ Approach In This Patient Population

Mari Kilner, Jennifer Collins, Ashley Price, Annette Richardson, Julie Samuel, Christine Straughan, Gail Jones

Blood (2013) 122 (21): 1716.

https://doi.org/10.1182/blood.V122.21.1716.1716

Published: 2013

Journal Articles

The Impact Of a Standardised Transcranial Doppler Training Programme In Screening Children With Sickle Cell Disease: A European Multicenter Perspective

Baba PD Inusa, MD, FRCPCH, Laura Sainati, MD, Raffaella Colombatti, MD PhD, Corrina McMahon, MD, FRCPath, MB, MRCP, Claire Hemmaway, Soundrie Padayachee

Blood (2013) 122 (21): 983.

https://doi.org/10.1182/blood.V122.21.983.983

Published: 2013

Journal Articles

Impact of Apixaban On a Large Panel of Routine or More Specific Coagulation Assays.

Jonathan Douxfils, François Mullier, Christian Chatelain, Bernard Chatelain, Dogné Jean-Michel

Blood (2012) 120 (21): 2275.

https://doi.org/10.1182/blood.V120.21.2275.2275

Published: 2012

Journal Articles

A Network of Treatment Centers and Standardisation of Treatment Protocol Leads to Reduction in Mortality in Acute Promyelocytic Leukemia (APL)

Anand P. Jillella, MD, Farrukh Awan, MD, MS, Ravindra B. Kolhe, MD, PhD, Jeremy M Pantin, MB.BS., Devi D Morrison, Vamsi Kota, MBBS

Blood (2012) 120 (21): 4317.

https://doi.org/10.1182/blood.V120.21.4317.4317

Published: 2012

Journal Articles

One Step Quantitative Molecular Approach for Detection of BCR/ABL Translocation and for Monitoring and Follow up of the Minimal Residual Disease in CML Patients Under Tyrosine Kines Inhibitors Treatment

Filomena Daraio, Dr, Davide Barberis, PhD, Francesca Crasto, Dr, Giovanna Rege-Cambrin, Cristina Olivo, PhD, Matteo Renzulli, PhD, Rosy Volpi, PhD, Roberta Lorenzatti, Dr, Carmen Fava, MD, Enrico Gottardi, MD, Giuseppe Saglio, MD

Blood (2012) 120 (21): 4435.

https://doi.org/10.1182/blood.V120.21.4435.4435

Published: 2012

Journal Articles

ZAP-70 Expression Measured by Quantitative PCR (QPCR) As a Prognostic Marker in Chronic Lymphocytic Leukaemia (CLL)

Peter Mollee, MBBS, FRCPA, FRACP, MMSc, Raymond H. Banh, MBBS, FRACP, FRCPA, Catherine Cheung, Russell Saal, Lynne Chambers, Tennille Pelly, Devinder S Gill, MD

Blood (2011) 118 (21): 4602.

https://doi.org/10.1182/blood.V118.21.4602.4602

Published: 2011

Journal Articles

International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MRD-ALL Consortia

Blood (2011) 118 (21): 2535.

https://doi.org/10.1182/blood.V118.21.2535.2535

Published: 2011

Journal Articles

Circulating Microparticles and Microparticle Procoagulant Activity in Patients with Antiphospholipid Antibodies

Karen A Breen, MB, Katy Sanchez, Nicola Kirkman, Kiran Parmar, MSc, Beverley J Hunt, FRCP, FRCPath, MD

Blood (2011) 118 (21): 5244.

https://doi.org/10.1182/blood.V118.21.5244.5244

Published: 2011

Journal Articles

A Phase IIIb Multicentre Open-Label Study of Nilotinib in Adult Patients with Newly Diagnosed BCR-ABL Positive Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A European Clinical Initiative with EUTOS Collaboration for Standardisation of Molecular Remission

Francis J. Giles, MB, MD, FRCPI, FRCPath, Gianantonio Rosti, MD, Gert Ossenkoppele, MD, PhD, Michel Tulliez, Jesper Stentoft, MD, PhD, Aristoteles Giagounidis, MD, Francesco Nobile, MD, Philipp D. le Coutre, MD, Norbert Gattermann, MD, Laimonas Griskevicius, Nicholas C.P. Cross, PhD, FRCPath, Sarah Hill, BSc (hons), PhD, MICR, Peter Schuld, PhD, Angela Pellegrino, Domenico Magazzù, Andreas Hochhaus, MD

Blood (2011) 118 (21): 2759.

https://doi.org/10.1182/blood.V118.21.2759.2759

Published: 2011

Journal Articles

Towards DNA-Based Monitoring of Therapy In Chronic Myeloid Leukemia

Alexander A. Morley, MD, FRACP, FRCPA, MB, BS, Paul Bartley, PhD, David Ross, MBBS, PhD, Sue Latham, BSc, Brad Budgen, B, Biotech, Susan Branford, PhD, Timothy Hughes, MD, MBBS

Blood (2010) 116 (21): 2284.

https://doi.org/10.1182/blood.V116.21.2284.2284

Published: 2010

Journal Articles

Fluorescent PCR Based Gene Dose Assessment for Detection of Deletion Mutations in the FIX Gene Among Carriers of Hemophilia B.

Eunice Sindhuvi Edison, Ph.D, G. Sankari Devi, B.Sc, G. Jayandharan, Ph.D, Shaji R Velayudhan, Ph.D, Auro Viswabandya, MD, Vikram Mathews, MD, Mammen Chandy, MD, Alok Srivastava, MD

Blood (2009) 114 (22): 3486.

https://doi.org/10.1182/blood.V114.22.3486.3486

Published: 2009

NARROW

I-Care for MDS: Development of Guidelines-Based Indicators for Appropriate Care in Adult Patients with Myelodysplastic Syndromes

Is Durability of Response Reported in Refractory CTCL: A Systematic Review

Quantification of BCR-ABL with Digital PCR Results in a Significantly Lower Rate of Deep Molecular Responses When Compared to RT-qPCR in CML Patients Treated in the ENEST1st Trial

Whole Body (WB) MRI in Newly Diagnosed Multiple Myeloma (MM): Fat Fraction Changes at 8 Weeks Predict Response to Induction with Bortezomib Regimens

Targeting Clotting Factor VIII Plasma Values in the Perioperative Setting in Hemophilia a: “Tackling a Moving Target” (“OPTI-CLOT” Studies)

Exceeding MR5.0 Sensitivity in Routine BCR-ABL1 Analysis Using Multiplex Digital PCR

Towards Successful Implementation of Pharmacokinetic-Guided Prophylactic Dosing of Clotting Factor Concentrate in Hemophilia; The Do’s and Don’ts after Discrete Choice Experiment Analysis

A Comparison of Droplet Digital PCR and Quantitative RT-PCR for Low Level BCR-ABL in CML Patients with Molecular Responses

Development and Evaluation of the Clinical Utility of a Next Generation Sequencing (NGS) Tool for Myeloid Disorders

Reducing Central Venous Catheter Infection Rates Amongst Hematology Patients: Real-Life Implementation Of a ‘Matching Michigan’ Approach In This Patient Population

The Impact Of a Standardised Transcranial Doppler Training Programme In Screening Children With Sickle Cell Disease: A European Multicenter Perspective

Impact of Apixaban On a Large Panel of Routine or More Specific Coagulation Assays.

A Network of Treatment Centers and Standardisation of Treatment Protocol Leads to Reduction in Mortality in Acute Promyelocytic Leukemia (APL)

One Step Quantitative Molecular Approach for Detection of BCR/ABL Translocation and for Monitoring and Follow up of the Minimal Residual Disease in CML Patients Under Tyrosine Kines Inhibitors Treatment

ZAP-70 Expression Measured by Quantitative PCR (QPCR) As a Prognostic Marker in Chronic Lymphocytic Leukaemia (CLL)

International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MRD-ALL Consortia

Circulating Microparticles and Microparticle Procoagulant Activity in Patients with Antiphospholipid Antibodies

A Phase IIIb Multicentre Open-Label Study of Nilotinib in Adult Patients with Newly Diagnosed BCR-ABL Positive Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A European Clinical Initiative with EUTOS Collaboration for Standardisation of Molecular Remission

Towards DNA-Based Monitoring of Therapy In Chronic Myeloid Leukemia

Fluorescent PCR Based Gene Dose Assessment for Detection of Deletion Mutations in the FIX Gene Among Carriers of Hemophilia B.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only